Avience Biomedicals Share Price

Avience Biomedicals Limited was originally incorporated as Private Limited Company as Avience Biomedicals Private Limited on December 23, 2019 with the Registrar of Companies, Delhi. Later, Companys status got converted into a Public Limited Company, the name of the Company was changed to Avience Biomedicals Limited and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi.Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of VitroDiagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections.The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and goodquality solutions. The Company has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs. Being purely into B2B and B2G market, products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the Company also act as distributors and traders of medical equipments. A new production facility was established in Noida in 2021 thereby starting its ecommerce operations. The new production facility commenced at the Medical Device Park in FY25. The Company came up with the IPO by issuing 14,53,800 equity shares having face value Rs 10/ each and raised a fresh issue of 30.23 crore on 22 June 2026.